Application and Prospects of Traditional Chinese Medicine in the Treatment of Alzheimer's Disease

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive memory decline and cognitive dysfunction, primarily affecting the elderly. Approximately 50 million people worldwide are currently affected, with projections suggesting an increase to 152 million by 2050, especially among individuals over 65, where the incidence rate can be as high as 30%. This phenomenon significantly reduces the quality of life for patients and imposes substantial psychological and economic burdens on families and society. Therefore, finding effective treatment options is crucial. In recent years, Traditional Chinese Medicine (TCM) has gradually shown its potential in the treatment of AD. TCM views AD as a form of “dementia” or “amnesia,” attributing its root causes to dysfunctions of organs such as the kidneys and spleen, as well as deficiencies in qi (vital energy) and blood. Through methods like regulating qi and blood and strengthening kidney function, TCM aims to improve symptoms via a holistic approach. Many herbal formulas, such as Tianma Guoteng Decoction and Angong Niuhuang Pill, have been widely studied, demonstrating promising neuroprotective effects. Furthermore, both domestic and international studies indicate that TCM has made positive strides in the clinical application of AD, particularly in multicenter clinical trials, showing improvements in cognitive abilities and delays in disease progression. Herbal components such as astragalus polysaccharides, ginsenosides, curcumin, and Ginkgo biloba extract (GBE) exhibit significant neuroprotective effects through mechanisms like antioxidation, anti-inflammation, and the clearance of beta-amyloid (Aβ) protein. However, standardization and clinical validation remain major challenges to its widespread application. Looking ahead, integrating modern medical research methods, such as molecular biology and genetics, will provide new perspectives for TCM in the treatment of AD, facilitating the extraction and application of its effective components, thereby improving patients’ quality of life. Overall, TCM has achieved significant success in the treatment of AD, but further in-depth research is needed to fully realize its potential.

Authors

Institutions

Publication Details

Journal
IETI Transactions on Data Analysis and Forecasting (iTDAF)
Published
2025-01-10
DOI
https://doi.org/10.3991/itdaf.v2i4.53111
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Application and Prospects of Traditional Chinese Medicine in the Treatment of Alzheimer's Disease

Jinghui Sung, Zikang Jiang, Yuanpeng Huang
IETI Transactions on Data Analysis and Forecasting (iTDAF)
Alzheimer's disease research and treatments
article

Application and Prospects of Traditional Chinese Medicine in the Treatment of Alzheimer's Disease

Jinghui Sung, Zikang Jiang, Yuanpeng Huang
article en

Abstract

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive memory decline and cognitive dysfunction, primarily affecting the elderly. Approximately 50 million people worldwide are currently affected, with projections suggesting an increase to 152 million by 2050, especially among individuals over 65, where the incidence rate can be as high as 30%. This phenomenon significantly reduces the quality of life for patients and imposes substantial psychological and economic burdens on families and society. Therefore, finding effective treatment options is crucial. In recent years, Traditional Chinese Medicine (TCM) has gradually shown its potential in the treatment of AD. TCM views AD as a form of “dementia” or “amnesia,” attributing its root causes to dysfunctions of organs such as the kidneys and spleen, as well as deficiencies in qi (vital energy) and blood. Through methods like regulating qi and blood and strengthening kidney function, TCM aims to improve symptoms via a holistic approach. Many herbal formulas, such as Tianma Guoteng Decoction and Angong Niuhuang Pill, have been widely studied, demonstrating promising neuroprotective effects. Furthermore, both domestic and international studies indicate that TCM has made positive strides in the clinical application of AD, particularly in multicenter clinical trials, showing improvements in cognitive abilities and delays in disease progression. Herbal components such as astragalus polysaccharides, ginsenosides, curcumin, and Ginkgo biloba extract (GBE) exhibit significant neuroprotective effects through mechanisms like antioxidation, anti-inflammation, and the clearance of beta-amyloid (Aβ) protein. However, standardization and clinical validation remain major challenges to its widespread application. Looking ahead, integrating modern medical research methods, such as molecular biology and genetics, will provide new perspectives for TCM in the treatment of AD, facilitating the extraction and application of its effective components, thereby improving patients’ quality of life. Overall, TCM has achieved significant success in the treatment of AD, but further in-depth research is needed to fully realize its potential.

IETI Transactions on Data Analysis and Forecasting (iTDAF)Vol. 2(4)
Fujian University of Traditional Chinese Medicine (CN)
Openalex Percentile: Top 99%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.